Key Takeaways
- The S&P 500 ended 0.2% higher on Monday, Jan. 13, 2025, ahead of this week’s inflation data and the first wave of earnings reports from the nation’s biggest banks.
- Moderna shares plummeted after the biotech firm slashed its 2025 revenue guidance, citing uncertain vaccine demand.
- Shares of managed care companies moved higher following the U.S. government’s proposal to raise Medicare Advantage reimbursement rates next year.
Major U.S. equities indexes were mixed to start a new trading week ahead of inflation data that could provide some clarity on the interest-rate outlook for 2025. Earnings reports from the largest U.S. banks are also set for release this week.
After trading in negative territory for most of the day, the S&P 500 rallied in the afternoon to close Monday’s session with a gain of 0.2%. The Dow was up 0.9%, while the tech-heavy Nasdaq slipped 0.4%.
Shares of Mosaic (MOS) jumped 8%, the most of any S&P 500 stock, as the fertilizer maker announced an agreement to sell its Patos de Minas phosphate mine in Brazil to a local operator. A report published last week by Zacks Equity Research suggested that Mosaic is poised to benefit from upbeat phosphate and potash demand trends as well as cost-cutting initiatives aimed at navigating a challenging environment for fertilizer prices.
It was also a positive day for shares of fellow agricultural nutrients manufacturer CF Industries (CF), as investment bank Piper Sandler upgraded the stock to “overweight” from “underweight.” CF stock rose 7.6% as analysts predicted that reduced grain production in the U.S. and an improving outlook for grain prices would help underpin strong pricing in the company’s key nitrogen fertilizer market.
Diagnostics and life sciences firm Revvity (RVTY) said it had received regulatory approval for its automated test for measuring free testosterone levels. The company also announced a neonatal sequencing research partnership with Element Biosciences. Revvity shares gained 7.8%.
Shares of healthcare companies with exposure to managed care plans moved higher Monday following last week’s proposal by the U.S. government to boost Medicare Advantage reimbursement rates by more than 4% in 2026. Shares of CVS Health (CVS) jumped 7.3%, while Humana (HUM) shares were up 6.8%.
Biotech and pharma giant Moderna (MRNA) slashed its 2025 sales guidance by $1 billion, noting it expects revenue to be weighted toward the second half of the year and to be generated primarily by its COVID-19 and respiratory syncytial virus vaccines. Although Moderna also announced plans to cut costs by $1 billion this year and another $500 million in 2026, its shares plunged 16.8%, the steepest loss in the S&P 500.
As tragic wildfires devastate Southern California, shares of area electric utility Edison International (EIX) extended the heavy declines posted last week, dropping 11.9% on Monday. Fire agencies are reportedly investigating whether electrical equipment from subsidiary Southern California Edison’s could have played a role in igniting the Hurst Fire.
Constellation Energy (CEG) shares sank 8.5%, reversing some of Friday’s surge of more than 25% posted by the stock after the energy producer announced an agreement to acquire rival Calpine. The $26.6 billion deal expands Constellation’s footprint in California and Texas, and the company said the combination will create the largest clean energy provider in the U.S.
